MdScripts' recent partnership with Appriss Health provides clinicians with one-click, point-of-care access to prescription drug monitoring program (PDMP) data, advanced analytics, and tools and resources designed to improve patient safety and outcomes.
By eliminating long-intervals, state level lag-time between dispensing and submission, and creating an easily accessible and physician-friendly gateway, MDScripts is providing clinicians unparalleled access to information that supports more informed and timely decision making and results in more effective prevention and management of substance abuse disorder (SUD).
Overdose deaths resulting from prescription opioids in the United States have quadrupled over the last 15 years1 140 people in the United States die each day as a result of overdosing on opioids2. This growing epidemic of opioid addiction and misuse, including prescription pain medication, recently led to President Trump declaring a public health emergency to deal with the crisis3.
As federal, state, and local governments struggle/scramble to contain the opioid crisis, the data continues to support the CDC's findings that include PDMPs are among the most promising state-level intervention to improve the opioid prescribing, inform clinical practice, and protect patients at risk4.
Consider the following:
A 2016 study released by the Department of Health and Human Services (HHS) concluded that implementing a PDMP in the point-of-care setting reduced the rate of prescribing a Schedule II opioid, including codeine, morphine, hydrocodone, by over 30%. Adding to the effectiveness of a PDMP in the clinical setting, the HHS also found these results to be sustained for three years after initial findings6.
In response to these findings, and in an attempt to curtail "doctor shopping" and to better identify and prevent SUD, 49 of the 50 states (the exception being Missouri) now collect data on all dispensed controlled substances; at least 48 state have also started to monitor drug data from other states7 8
Several states now mandate that physicians report any controlled substance prescribed and dispensed by the close of business the following day; in some states, failure to report is now being treated as a crime, and is considered a misdemeanor.
However, recent surveys of primary care physicians indicate that while over 70% of primary care physicians are aware of their state's PDMPs, only around 50% of physicians have ever used it. In states that require doctors to record specific information allowing prescriptions and dispensing of controlled substances to be monitored and tracked, nearly 60% of providers reported that recording this information is takes too long; 30% found the format not to be user friendly9.
MDScripts' application provides a one-click point of service solution to ensure physicians are compliant with state PDMP reporting regulations. In fact, MDScripts' system automatically provides daily reports to the appropriate state when a physician dispenses a controlled substance (each evening in most states; in real time for Oklahoma). MDScripts' application integrates into normal workflow and provides physicians with a data-reporting platform that requires all reporting elements be present before items are allowed to be dispensed.
MDScripts’ integration of Appriss Health’s PMP Gateway managed service platform increases physician utilization of PDMP data and other information up front for every patient by utilizing a sizeable network of electronic health record (EHR) and pharmacy management systems.
Clinicians now have access to MDScripts one-click process which eliminates the time consuming process of manually logging into each individual state's PDMP website to enter a patient's name and demographics. In addition, the PMP Gateway provides healthcare prescribers and dispensers:
By integrating Prescription Drug Monitoring Program Data and a Comprehensive Substance Use Disorder Platform directly into clinician workflow, MdScripts is providing clinicians a seamless solution that provides access to prescription drug information and improves efficiency and effectiveness in their day-to-day operations.
1 "Prescription Drug Monitoring Programs: Evolution and Evidence | LDI." 8 Jun. 2017, https://ldi.upenn.edu/brief/prescription-drug-monitoring-programs-evolution-and-evidence. Accessed 20 Jun. 2018.
2 "Opioid Overdose Crisis - National Institute ...." https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis. Accessed 20 Jun. 2018.
3 "Trump administration declares opioid crisis a public health ... - NPR." 26 Oct. 2017, https://www.npr.org/2017/10/26/560083795/president-trump-may-declare-opioid-epidemic-national-emergency. Accessed 20 Jun. 2018.
4 "What States Need to Know about PDMPs | Drug Overdose | CDC ...." 3 Oct. 2017, https://www.cdc.gov/drugoverdose/pdmp/states.html. Accessed 20 Jun. 2018.
5 "Opioid Overdose Crisis - National Institute ...." https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis. Accessed 20 Jun. 2018.
6 "Prescription Drug Monitoring Programs Are Associated ... - NCBI - NIH." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336205/. Accessed 20 Jun. 2018.
7 "Prescription Drug Monitoring Programs: Evolution and Evidence | LDI." 8 Jun. 2017, https://ldi.upenn.edu/brief/prescription-drug-monitoring-programs-evolution-and-evidence. Accessed 20 Jun. 2018.
8 "States require doctors to use prescription drug monitoring systems for ...." 15 Jan. 2018, https://www.washingtonpost.com/national/health-science/states-require-doctors-to-use-prescription-drug-monitoring-systems-for-patients/2018/01/12/c76807b8-f009-11e7-97bf-bba379b809ab_story.html. Accessed 20 Jun. 2018.
9 "Only 53 Percent of Doctors Use Their State Prescription Drug ...." 3 Mar. 2015, https://drugfree.org/learn/drug-and-alcohol-news/53-percent-doctors-use-state-prescription-drug-monitoring-program-study/. Accessed 20 Jun. 2018.
Boulder, CO, March 28, 2018 – MDScripts, a leading provider of Clinical Software Applications, today announced that its MDScripts (clinical dispensing), RXBilling (pharmaceutical billing and collection) MDPatients (integrated lab testing), and PMPReport (controlled substance reporting) applications have earned Certified status for information security by HITRUST.
HITRUST CSF Certified status demonstrates that the organization’s suite of clinical dispensing, billing, lab testing, and controlled substance reporting applications have met key regulations and industry-defined requirements and are appropriately managing risk. This achievement places MDScripts in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.
"Organizations like ours are under increasing pressure to meet complex compliance requirements that include technical and process elements such as HIPAA, NIST, ISO and COBIT," said Gary W. Mounce, President at MDScripts. "The HITRUST CSF is the gold standard that needs to be met, and MDScripts is pleased to be able to demonstrate its commitment by achieving HITRUST CSF Certification."
"The HITRUST CSF has become the information protection framework for the health care industry, and the CSF Assurance program is bringing a new level of effectiveness and efficiency to third-party assurance," said Ken Vander Wal, Chief Compliance Officer, HITRUST. "The HITRUST CSF Certification is now the benchmark that organizations required to safeguard PHI are measured against with regards to information protection."
Contact us today to learn more about MDScripts or to request a demo of the software. We can be reached by phone, email or by submitting the contact form below. We look forward to hearing from you!
If you are interested in opportunities at MDScripts, we'd love to hear from you.